We are live on ! Find out more
NED

Nancy E. Dempze Portfolio holdings

AUM $182M
1-Year Est. Return 16.09%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$146M
AUM Growth
+$14.4M
Cap. Flow
+$11M
Cap. Flow %
7.56%
Top 10 Hldgs %
38.97%
Holding
81
New
19
Increased
31
Reduced
18
Closed

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$1.02M
2
NVS icon
Novartis
NVS
+$628K
3
NVDA icon
NVIDIA
NVDA
+$550K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$125K
5
PG icon
Procter & Gamble
PG
+$109K

Sector Composition

Rank Sector Weight
1 Technology 28.64%
2 Healthcare 17.91%
3 Industrials 11.49%
4 Consumer Discretionary 9.89%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
51
Union Pacific
UNP
$172B
$300K 0.21%
1,325
+135
+11% +$31.6K
MRSH
52
Marsh
MRSH
$91.4B
$295K 0.2%
1,400
+150
+12% +$30.8K
GPN icon
53
Global Payments
GPN
$23.8B
$290K 0.2%
+3,000
New +$331K
BF.A icon
54
Brown-Forman Class A
BF.A
$13.4B
$265K 0.18%
+6,000
New +$286K
TMO icon
55
Thermo Fisher Scientific
TMO
$214B
$263K 0.18%
475
+20
+4% +$11.5K
GIS icon
56
General Mills
GIS
$19.4B
$253K 0.17%
+4,000
New +$275K
CMCSA icon
57
Comcast
CMCSA
$84B
$243K 0.17%
+6,200
New +$243K
APTV icon
58
Aptiv
APTV
$12.3B
$234K 0.16%
3,318
+180
+6% +$13.8K
AXP icon
59
American Express
AXP
$228B
$232K 0.16%
+1,000
New +$232K
IBM icon
60
IBM
IBM
$209B
$225K 0.15%
+1,300
New +$226K
AIG icon
61
American International
AIG
$41.8B
$223K 0.15%
+3,000
New +$229K
TXN icon
62
Texas Instruments
TXN
$255B
$222K 0.15%
+1,140
New +$211K
CATC
63
DELISTED
CAMBRIDGE BANCORP
CATC
$207K 0.14%
+3,000
New +$195K
NEE icon
64
NextEra Energy
NEE
$183B
$204K 0.14%
+2,882
New +$204K

Similar funds

Nancy E. Dempze's Q2 2024 Portfolio in Review

As of Q2 2024, Nancy E. Dempze held 81 positions worth $146M, up 11% from $131M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Nancy E. Dempze deployed $11M of net new capital in Q2 2024, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 1,100 shares worth $1.16M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Nike, an estimated $1.02M trimmed.

  • Nancy E. Dempze's largest Q2 2024 buy was Regeneron Pharmaceuticals: 1,100 shares worth $1.16M.
  • Nancy E. Dempze added most to Visa in Q2 2024, an estimated $1.34M increase.
  • Nancy E. Dempze's biggest Q2 2024 reduction was Nike, cutting an estimated $1.02M.
  • Nancy E. Dempze's ten largest holdings make up 39% of its $146M portfolio in Q2 2024.
  • Nancy E. Dempze opened 19 new positions and closed 0 in Q2 2024.
  • Nancy E. Dempze's portfolio value rose 11% quarter-over-quarter to $146M.

Based on Nancy E. Dempze's 13F filing for Q2 2024, filed 12 Aug 2024.